Second New MS Drug Mavenclad (Cladribine) Secures FDA Approval

MONDAY, April 1, 2019 -- The U.S. Food and Drug Administration has approved another new multiple sclerosis drug -- the second in one week. Mavenclad (cladribine) pills can be used to treat relapsing forms of MS in adults, including...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news